Bli medlem
Bli medlem

Du är här

2020-07-15

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/S
Company announcement                                                                              

No. 41/2020                                                                                                  
Company Registration No. 32266355

                                                                                                                

Copenhagen, Denmark, July 15, 2020 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme:

1 Details of the Reporting Person / Closely Associated Person
a) Name
Kim Stratton
2 Reason for the notification
a) Position/status
Chief Executive Officer
b) Initial notification/Amendment
Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Orphazyme A/S
b) LEI code
54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code
Shares
ISIN DK0060910917
b) Nature of the transaction
Purchase of shares
c) Price(s) and volume(s)

Price(s)Volume(s)
DKK92.914
DKK9315
DKK93200
DKK9381
DKK931
DKK9366
DKK9339
DKK93.2179
DKK93.2119
DKK93.2202
DKK93.2100
DKK93.3500
DKK93.3500
DKK93.4260
DKK93.4200
DKK93.4500
DKK93.5300
DKK93.6388
DKK93.7500
DKK93.7500
DKK
Författare ORPHAZYME A/S

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.